Impax Laboratories
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Impax Laboratories's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 6% to $775,787,000. The net income raised on -$469,287,000 and profit margin reached -60%. Total operating expenses were $546,491,000.
Profit Margin
| 2013 | 511.50M | 101.25M | 19.8% |
|---|---|---|---|
| 2014 | 596.04M | 57.35M | 9.62% |
| 2015 | 860.46M | 38.99M | 4.53% |
| 2016 | 824.42M | -472.03M | -57.26% |
| 2017 | 775.78M | -469.28M | -60.49% |
IPXL Income Statement (2013 – 2017)
| 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 775.78M | 824.42M | 860.46M | 596.04M | 511.50M |
Cost of revenue | 535.12M | 975.53M | 508.06M | 283.39M | 312.20M |
Gross profit | 240.66M | -151.10M | 352.40M | 312.65M | 199.3M |
Operating exp. | |||||
Research and development | 80.84M | 133.43M | 76.98M | 79.11M | 68.85M |
Selling and marketing | 0 | 0 | 0 | 0 | 120.28M |
Total operating expenses | 546.49M | 335.26M | 278.26M | 218.50M | 205.68M |
Operating income | -402.69M | 494.18M | 69.56M | 88.81M | -5.08M |
Other income (expenses), net | -48.26M | -1.07B | -10.2M | 1.74M | 152.02M |
Income before tax | -450.96M | -576.32M | 59.36M | 90.55M | 146.94M |
Income tax expense | 18.32M | -104.29M | 20.37M | 33.20M | 45.68M |
Net income | -469.28M | -472.03M | 38.99M | 57.35M | 101.25M |
Earnings per share | |||||
Basic EPS | -6.53 | -6.63 | 0.56 | 0.84 | 1.51 |
Diluted EPS | -6.53 | -6.63 | 0.54 | 0.81 | 1.47 |
| Data source |